Thursday, March 22, 2012

Seroquel XR patent ruled invalid by UK court

The UK court today ruled the Seroquel XR patent as invalid. The patent was challenged by Accord Healthcare Limited, Intas Pharmaceuticals Limited, Hexal AG and Sandoz Limited, Teva UK Limited, and Teva Pharmaceutical Industries Limited.

No comments:

Post a Comment